Allstate is a US personal-lines property and casualty insurer selling auto, homeowners and other cover through exclusive agents, independent agencies and direct channels.
Latest research: initiation, Nov 21, 2026 · Market value $66.3bn
ALLBuyTarget $309.41+18% expected
Our view, Nov 21, 2026
The price assumes a 96% combined ratio; we see 94% and 18% upside
Allstate is a top-four US personal-lines insurer, earning about $60 billion of premiums a year. At $266.59 the shares imply a 96.0% mid-cycle combined ratio and a 15.7% return on equity, against our 94.0% and 18.7%.
Where the price could be in 12 months
Circle size shows how likely we think each case is. Case values are 12-month values; the target weights all three and adds 12 months of expected return at a 9.21% cost of equity less a 1.62% dividend yield. Source: Penmark Research.
For FY26E we forecast earnings per share of $40.63, against analysts’ $37.90. For FY27E we forecast earnings per share of $29.46, against analysts’ $27.58.
Our earnings per share forecasts against analysts’
Our estimateAnalysts’ forecast
Earnings per share as the report gives them. Analysts’ forecast is the consensus figure in the report. Source: Penmark Research estimates.
Auto loss-cost inflation repeating the 2022 trough (103.6% underlying auto ratio) drives the $205 bear case (30% probability).
A 1pp higher cost of equity cuts the weighted value to $256.24 and the target to $278.24, moving the rating to Hold (−$31 a share weighted).
Severe catastrophes lifting the homeowners catastrophe load toward the 38.6% FY23 level (−$2.5 a share) would erode underwriting earnings and pause buybacks.
What bears get right. A 1-point higher cost of equity cuts our target to $278.24, a Hold. A deeper auto loss-cost cycle that repeats 2022 drives the bad case, worth $205.02 a share today.
Dates to watch
We expect $11.26 of earnings per share against about $8.49 implied by analysts, and a new buyback.
Auto rate restarts should keep the auto underlying ratio at 93.0% or better.
Shows whether the combined ratio holds near 92% to 94%, or slips toward the 96% priced in.
We expect $29.46 of earnings per share, 6.8% above analysts’ $27.58.
Penmark Research rates The Allstate (ALL) Buy, with a 12-month price target of $309.41, +16% from the $266.59 share price at our latest report. We expect a total return of more than 10% over the next 12 months: the move to our price target, plus dividends.
What is the ALL price target?
Our 12-month price target for The Allstate is $309.41, set in our initiation of Nov 21, 2026. Our bear case values the shares at $220.58 and our bull case at $393.35. The target comes from the probability-weighted value of our bull, base and bear cases.
Will The Allstate stock go up?
Our The Allstate stock forecast is a 12-month price target of $309.41, +16% from the $266.59 share price at our latest report, which is why we rate it Buy. Our bear case puts the shares at $220.58 (-17%) and our bull case at $393.35 (+48%). No forecast is certain; the main risks are below.
What does The Allstate do?
Allstate is a US personal-lines property and casualty insurer selling auto, homeowners and other cover through exclusive agents, independent agencies and direct channels.
What are the main risks to The Allstate stock?
Auto loss-cost inflation repeating the 2022 trough (103.6% underlying auto ratio) drives the $205 bear case (30% probability).
A 1pp higher cost of equity cuts the weighted value to $256.24 and the target to $278.24, moving the rating to Hold (−$31 a share weighted).
Severe catastrophes lifting the homeowners catastrophe load toward the 38.6% FY23 level (−$2.5 a share) would erode underwriting earnings and pause buybacks.
What is Penmark’s latest research on The Allstate?
Our latest report is our initiation of Nov 21, 2026, “Initiate at Buy with a $309 target as margins normalise more slowly than priced”. We initiate on Allstate at Buy with a $309.41 target, a +17.8% total return from $266.59, with Low conviction. At today’s price the stock implies a 96.0% normalised Property-Liability combined ratio and a 15.7% ROE, against our 94.0% and 18.7%, helped by a 3.3pp structural expense cut. Our adjusted EPS sits 7.2%…